These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36384763)

  • 1. Drugs for type 2 diabetes.
    Med Lett Drugs Ther; 2022 Nov; 64(1663):177-184. PubMed ID: 36384763
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for type 2 diabetes.
    Med Lett Drugs Ther; 2019 Nov; 61(1584):169-178. PubMed ID: 31770362
    [No Abstract]   [Full Text] [Related]  

  • 3. Ertugliflozin for type 2 diabetes.
    Med Lett Drugs Ther; 2018 Apr; 60(1545):70-72. PubMed ID: 29667948
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison chart: SGLT2 inhibitors.
    Med Lett Drugs Ther; 2020 Nov; 62(1611):e2-e4. PubMed ID: 33429417
    [No Abstract]   [Full Text] [Related]  

  • 5. Tirzepatide (Mounjaro) for type 2 diabetes.
    Med Lett Drugs Ther; 2022 Jul; 64(1654):105-107. PubMed ID: 35802842
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes.
    Med Lett Drugs Ther; 2019 Feb; 61(1566):26-28. PubMed ID: 30845101
    [No Abstract]   [Full Text] [Related]  

  • 7. Dapagliflozin/saxagliptin (Qtern) for type 2 diabetes.
    Med Lett Drugs Ther; 2018 Mar; 60(1543):55-56. PubMed ID: 29635266
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral semaglutide (Rybelsus) for type 2 diabetes.
    Med Lett Drugs Ther; 2019 Oct; 61(1583):166-168. PubMed ID: 31770356
    [No Abstract]   [Full Text] [Related]  

  • 9. In brief: Trijardy XR - a new 3-drug combination for Type 2 diabetes.
    Med Lett Drugs Ther; 2020 Jun; 62(1599):88. PubMed ID: 32555117
    [No Abstract]   [Full Text] [Related]  

  • 10. In brief: Expanded heart failure indication for empagliflozin (Jardiance).
    Med Lett Drugs Ther; 2022 Apr; 64(1648):57. PubMed ID: 35436772
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis.
    Zhang YS; Zheng YD; Yuan Y; Chen SC; Xie BC
    Front Endocrinol (Lausanne); 2021; 12():735824. PubMed ID: 34721294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic agents and cardiovascular outcomes in patients with heart diseases.
    Cheng JWM; Badreldin HA; Patel DK; Bhatt SH
    Curr Med Res Opin; 2017 Jun; 33(6):985-992. PubMed ID: 28097882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action.
    Gupta P; Bala M; Gupta S; Dua A; Dabur R; Injeti E; Mittal A
    Pharmacol Res; 2016 Nov; 113(Pt A):636-674. PubMed ID: 27697646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In brief: Canagliflozin and lower limb amputations.
    Med Lett Drugs Ther; 2020 Sep; 62(1607):152. PubMed ID: 32960870
    [No Abstract]   [Full Text] [Related]  

  • 15. In brief: Higher-dose semaglutide (Ozempic) for type 2 diabetes.
    Med Lett Drugs Ther; 2022 May; 64(1650):79. PubMed ID: 35536124
    [No Abstract]   [Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-diabetic drugs and weight loss in patients with type 2 diabetes.
    Lazzaroni E; Ben Nasr M; Loretelli C; Pastore I; Plebani L; Lunati ME; Vallone L; Bolla AM; Rossi A; Montefusco L; Ippolito E; Berra C; D'Addio F; Zuccotti GV; Fiorina P
    Pharmacol Res; 2021 Sep; 171():105782. PubMed ID: 34302978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulins for type 2 diabetes.
    Med Lett Drugs Ther; 2019 May; 61(1571):65-68. PubMed ID: 31169803
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanded table: some available insulins for type 2 diabetes.
    Med Lett Drugs Ther; 2019 May; 61(1571):e73-e77. PubMed ID: 31169807
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.